本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Axsome Therapeutics, Inc.

205.48
+0.08000.04%
盤後203.00-2.4797-1.21%17:36 EDT
成交量:73.15萬
成交額:1.50億
市值:107.63億
市盈率:-54.53
高:209.53
開:207.58
低:200.19
收:205.40
52周最高:260.19
52周最低:112.90
股本:5,238.08萬
流通股本:4,383.14萬
量比:1.34
換手率:1.67%
股息:- -
股息率:- -
每股收益(TTM):-3.7685
每股收益(LYR):-3.6821
淨資產收益率:-245.10%
總資產收益率:-16.31%
市淨率:129.20
市盈率(LYR):-55.81

資料載入中...

2026/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/08/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/28

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/15

重要事件披露

Form 8-K - Current report
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/09

重要事件披露

Form 8-K - Current report
2026/06/09

重要事件披露

Form 8-K - Current report
2026/06/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/03

重要事件披露

Form 8-K - Current report
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities